Literature DB >> 6424975

Pituitary and thyroid insufficiency in thalassaemic haemosiderosis.

D P Livadas, K Sofroniadou, A Souvatzoglou, M Boukis, L Siafaka, D A Koutras.   

Abstract

Thyroid and pituitary function tests using hypothalamic releasing factors were performed in seven patients with thalassaemia and secondary haemosiderosis and in a control group of seven healthy subjects. The TSH level in the thalassaemic patients (18.07 +/- 1.10 microU/ml) was higher than in the controls (1.01 +/- 0.14 microU/ml, P less than 0.001). After TRH administration the TSH values increased less than in controls. Serum thyroxine and FT41 values were lower in the group of patients with thalassaemia (76.7 +/- 7.8 nmol/l and 19.3 +/- 2.2) compared to the controls (116.1 +/- 6.9 nmol/l, P less than 0.005 and 38.6 +/- 3.6, P less than 0.001). The basal prolactin values did not differ significantly between the two groups, but after TRH administration the increment was significantly lower in thalassaemics than in controls (P less than 0.005). The basal LH values were lower in the thalassaemic patients (1.37 +/- 0.24 ng/ml) than in the controls (3.23 +/- 0.50 ng/ml) and did not increase significantly after LHRH administration. The FSH values were also lower in the thalassaemic group (0.46 +/- 0.15 ng/ml) compared to the controls (2.06 +/- 0.08 ng/ml, P less than 0.001), and increased only slightly after LHRH administration. We conclude that in thalassaemia pituitary deficiency exists, mostly of gonadotrophs, but possibly also for the thyrotrophs and the lactotrophs. Latent primary hypothyroidism has also been found in the thalassaemic group. The functional abnormalities found in both endocrine glands are best explained as a consequence of coexisting haemosiderosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424975     DOI: 10.1111/j.1365-2265.1984.tb03439.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Follow-up study of thyroid function in polytransfused thalassemic patients.

Authors:  M Maggiolini; G De Luca; M Bria; D Sisci; S Aquila; V Pezzi; M Lanzino; A Giorno; O Tamburrini; M Della Sala; E Corcioni; C Brancati; S Ando
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism.

Authors:  R Balducci; V Toscano; G Finocchi; G Municchi; A Mangiantini; B Boscherini
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

3.  Evaluation of hypothalamic-pituitary function in patients with thalassemia major.

Authors:  L Danesi; M Scacchi; M De Martin; A Dubini; P Massaro; A T Majolo; F Cavagnini; E E Polli
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

4.  Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients.

Authors:  Mohammed Saied Abdulzahra; Hussein Kadhem Al-Hakeim; Mahdi Muhammed Ridha
Journal:  Asian J Transfus Sci       Date:  2011-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.